B3S-22943-66721
3 vaccinations
4 coded responses
25 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 967 / HI
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Pfizer-BioNTech
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-09
- 2021-02-16
-
2021-02-18
Dose 2 — Pfizer-BioNTech
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-02-25
Health check-in — day 7, dose 2Feeling: Good · Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-03-04
Survey response — day 14, dose 2MedDRA: Medical counselling, Syncope, Unresponsive to stimuli, Urinary incontinence — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Fainting episode with loss of bladder control while unresponsive for 2 to 3 minutes. · Healthcare visit (other): Doctor advised that I should go to ER if it happens again and recommends further medical follow up.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-11
Survey response — day 21, dose 2MedDRA: Abdominal discomfort, Abdominal pain upper, Gastrointestinal disorder, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: GI symptoms continue to get worse. Multiple episodes of vomiting last night and stomach pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-20
- 2021-03-25
-
2021-04-01
Survey response — day 42, dose 2MedDRA: Blood test abnormal, Inflammatory marker increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bloodwork came back with elevated inflammatory markers.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-20
-
2021-06-08
Call successfulCompleted over the phone
-
2021-08-19
Survey response — 6 months, dose 2MedDRA: Exposure to SARS-CoV-2, Oropharyngeal pain, Tongue discolouration — Feeling: GoodFree text: After partially vaccinated household member became symptomatic and then tested positive for COVID, I also developed sore throat and discoloration of my tongue.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-07
Dose 3 — Pfizer-BioNTech
- 2022-02-18
- 2022-02-18
- 2022-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 3
Free text
Release 5 — day 14, dose 2
Symptoms: Fainting episode with loss of bladder control while unresponsive for 2 to 3 minutes.
Healthcare visit (other): Doctor advised that I should go to ER if it happens again and recommends further medical follow up.
Release 5 — day 21, dose 2
Symptoms: GI symptoms continue to get worse. Multiple episodes of vomiting last night and stomach pain.
Release 6 — day 42, dose 2
Symptoms: Bloodwork came back with elevated inflammatory markers.
Release 9 — 6 months, dose 2
Symptoms: After partially vaccinated household member became symptomatic and then tested positive for COVID, I also developed sore throat and discoloration of my tongue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Abdominal discomfort | ✓ | ✓ | ○ |
| SD | Abdominal pain upper | ✓ | ✓ | ✓ |
| SD | Blood test abnormal | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Inflammatory marker increased | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Syncope | ✓ | ✓ | ✓ |
| SD | Tongue discolouration | ✓ | · | ✓ |
| SD | Unresponsive to stimuli | ✓ | ✓ | ✓ |
| SD | Urinary incontinence | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release